aTYR PHARMA INC Repayments of Convertible Debt
aTYR PHARMA INC (ATYR) reported Repayments of Convertible Debt of $2.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2018-03-20
- aTYR PHARMA INC repayments of convertible debt for the quarter ending 2015-12-31 was $0.00.
- aTYR PHARMA INC repayments of convertible debt for the quarter ending 2015-09-30 was $0.00.
- aTYR PHARMA INC repayments of convertible debt for fiscal 2015 was $2.00M.
- aTYR PHARMA INC repayments of convertible debt for fiscal 2013 was $500.00K.
| Period end | Repayments of Convertible Debt 1 month | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $0.00 derived: sum of 2 quarters · filed 2018-03-20 | $2.00M 10-K · filed 2018-03-20 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.00M 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | $2.00M 10-Q · filed 2016-08-10 | ||||
| 2015-05-31 | $2.00M 10-Q · filed 2015-08-12 | ||||
| 2013-12-31 | $500.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |